CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation With Techorizon
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation With Techorizon
PR83128
VERONA, Italy, March 3, 2020 /PRNewswire=KYODO JBN/ --
CROMSOURCE announced today the achievement of a significant milestone in the
digital management of clinical research projects for their clients. In February
2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced
TheClinical digital environment. TheClinical, developed by Techorizon, consists
of customisable, integrated modules dedicated to the efficient digital
management of every aspect of clinical research and development projects.
Logo:
https://mma.prnewswire.com/media/1097884/CROMSOURCE___Techorizon_Logo.jpg
'Digitalisation is a key foundation of our working philosophy, and has been a
significant source of our investment for many years', commented CROMSOURCE CEO,
Dr. Oriana Zerbini. 'Our adoption and development of digital technologies
provides our clients with benefits in efficiency, quality and visibility on
their projects.'
'Our clients typically first consider CROMSOURCE in order to benefit from the
flexibility, experience and client focus for which we are already recognised',
added Kerry Dyson, Chief Operating Officer at CROMSOURCE. 'When they realise
that we also offer a suite of integrated in-house digital services uncommon in
other providers of mid-size, the strategic benefit to selecting CROMSOURCE as a
partner becomes clear'.
'As a member of the CROMSOURCE group of companies, Techorizon has been able to
develop digital applications which reflect exactly the needs of sponsors and
service providers working in clinical research', noted Silvio Severini,
Managing Director of Techorizon. 'The maturity and reliability of our fully
validated systems is reflected by reaching this important milestone of the
1000th project to be managed in our TheClinical environment by CROMSOURCE.'
About CROMSOURCE
CROMSOURCE is an ISO-certified, international contract research organisation
providing a comprehensive portfolio of services to the pharmaceutical,
biotechnology, and medical device industries. Specialising in clinical
development and staffing solutions, we offer a flexible approach to ensure our
clients' unique needs are supported. CROMSOURCE is unparalleled in offering an
End-to-End Guarantee covering trial timelines, enrolment, and price. CROMSOURCE
operates offices across all regions of Europe and North America. For more
information, visit www.cromsource.com.
About TECHORIZON
Techorizon are technology experts supplying the biopharmaceutical and medical
device industries with advanced IT solutions and services. As a subsidiary of
CROMSOURCE, Techorizon combines technical expertise with a deep understanding
of clinical research processes to deliver to its clients innovative and
customised technology solutions which seamlessly integrate to support all
aspects of clinical development. For more information, visit
www.techorizon.com.
SOURCE: CROMSOURCE
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。